Loading clinical trials...
Loading clinical trials...
A Pilot/Feasibility Study of Ledipasvir/Sofosbuvir as Treatment for Hepatitis C in Hematopoietic Cell Transplantation (HCT) Recipients.
Conditions
Interventions
Ledipasvir 90mg/Sofosubvir 400mg
Locations
2
United States
City of Hope
Duarte, California, United States
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
Start Date
September 1, 2017
Primary Completion Date
February 16, 2018
Completion Date
April 29, 2018
Last Updated
August 31, 2018
NCT07101588
NCT06093867
NCT05436418
NCT04146870
NCT07244419
NCT06494423
Lead Sponsor
Kaiser Permanente
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions